…& Analytics; Digital Transformation; Smart Lab Facilities; Sustainability in the Lab; Lab Operations & Efficiency, Training, Development & Talent; Connectivity & Collaboration; Artificial Intelligence, Machine & Deep Learning. These will…

Potential new drug candidates have been identified by a respiratory syncytial virus (RSV) artificial intelligence programme, as health officials warn of a “tripledemic” of SARS-CoV-2, influenza and RSV. The AI…

…breakthroughs in artificial intelligence (AI) and protein design, and uses methods pioneered by David Baker’s laboratory at the University of Washington’s Institute for Protein Design. BII is an international enterprise…

PhoreMost and ThinkCyte have entered a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI). The partnership leverages both companies’ technologies in high-throughput drug discovery,…

…degraders, molecular glues, and artificial intelligence for early drug discovery. Speakers from industry will include: AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, GlaxoSmithKline, Janssen, Johnson…

Using artificial intelligence, researchers at Chalmers University of Technology, Sweden have succeeded in designing synthetic DNA that controls the cells’ protein production. The technology can contribute to the development and…

…clever new anti-evolution combinations and dosing strategies. “We’re also confident that through the use of artificial intelligence in combination with detailed biological insights, we can find ways of combining existing…

…plate to shift the testing paradigm. The organisations will also highlight how recent innovations and the application of artificial intelligence are changing how robots interact with humans and their environment….

Poolbeg Pharma and partner OneThree Biotech have discovered novel drug targets for the treatment of respiratory syncytial virus (RSV) using an artificial intelligence (AI) programme. The OneThree team, using its…

Verge Genomics, a clinical-stage, tech-enabled biotechnology company using artificial intelligence (AI) and human data to transform drug discovery, has announced today that the first subject has been dosed in a…

…including the ongoing collaboration with WHO’s Hub for Pandemic and Epidemic Intelligence, to allow for faster data-driven decision-making at the earliest signs of an outbreak – when it matters most.”…

A new system utilising artificial intelligence (AI), ‘building-block’ chemistry and a molecule-making machine could speed up innovation and drug discovery, as well as make complex chemistry automated and accessible. Researchers…

…to a CRO that specialises in artificial intelligence (AI) and machine learning software to predict compounds that bind to a target. Company Z would generate candidates in weeks rather than…

…latest technology; trends and analysis; and articles and intelligence from the DDW quarterly publication including archived issues. To download the DDW app for Apple devices click here. To download the…

…the future will include decentralised elements and be more reliant on technologies like artificial intelligence, but also increasingly patient-centric. As a result of the pandemic companies and sites conducting clinical…

…Brainomix will leverage its e-ILD technology (automated artificial intelligence software) which has been trained to process high resolution chest CT (HRCT) data in patients with interstitial lung diseases. The data…